Ellagic acid

Ellagic acid purchased from MedChemExpress. Usage Cited in: Cell Prolif. 2025 May 19:e70064. [Abstract]

Customer Validation
Representative fluorescent images showing the internalisation of Dil‐labelled EVs and EA‐sEVs by HG‐HDFs and HG‐HEKs at 6 h; scale bar, 50 μm. Blue: DAPI, red: Dil, green: Phalloidine.

Ellagic acid purchased from MedChemExpress. Usage Cited in: Acta Pharm Sin B. 2023 Jun;13(6):2680-2700. [Abstract]

Customer Validation
After treatment with different concentrations of Ellagic acid (0-20 μM) for 24 h, the expression of SIRT6, SGK1, H3K9 and H3K56 in primary cardiomyocytes isolated from WT mice and LLC cells was examined by Western blotting. β-Actin was used as a loading control. Semiquantitative analyses of bands were performed using ImageJ software.

Ellagic acid purchased from MedChemExpress. Usage Cited in: Acta Pharm Sin B. 2023 Jun;13(6):2680-2700. [Abstract]

Customer Validation
Primary cardiomyocytes isolated from WT mice and LLC cells were transfected with SIRT6 siRNA or control siRNA. After pre-treated with Ellagic acid (10 μmol/L) for 24 h, Dox (0.5 μmol/L) was added to culture medium for subsequent 24 h, and apoptosis was analyzed by TUNEL assays. Representative images are shown (scale bar = 100 μm). The TUNEL-positive rates were quantified blindly in 5 images from different fields.

Ellagic acid purchased from MedChemExpress. Usage Cited in: Acta Pharm Sin B. 2023 Jun;13(6):2680-2700. [Abstract]

Customer Validation
Wild-type C57BL/6 mice were inoculated subcutaneously with 1.5 × 10⁶ LLC-Luc cells (LLC cells stably expressing the luciferase gene). After tumors became visible (approximately 7 days), the tumor-bearing mice were treated with Dox (10 mg/kg/week, i.v.) or/and Ellagic acid (100 mg/kg/2 days, i.g.) for 2 weeks. Tumor volume was visualized using the IVIS Imaging System before and after treatment, and representative bioluminescence images and quantitative analyses of the tumor-bearing mice are shown.

Ellagic acid purchased from MedChemExpress. Usage Cited in: Acta Pharm Sin B. 2023 Jun;13(6):2680-2700. [Abstract]

Customer Validation
Wild-type C57BL/6 mice were inoculated subcutaneously with 1.5 × 10⁶ LLC-Luc cells (LLC cells stably expressing the luciferase gene). After tumors became visible (approximately 7 days), the tumor-bearing mice were treated with Dox (10 mg/kg/week, i.v.) or/and Ellagic acid (100 mg/kg/2 days, i.g.) for 2 weeks. Cell morphology, fibrosis and apoptosis in the cardiac tissue of the tumor-bearing mice were examined by H&E, Masson and TUNEL staining, respectively. Cell morphology, proliferation and apoptosis and in the tumors were measured by H&E, Ki67 immunofluorescence and TUNEL staining, respectively.